Evidence
Mol Cell. 2024 May 16;84(10):1980-1994.e8. doi: 10.1016/j.molcel.2024.04.018.
ABSTRACT
Aggregation of proteins containing expanded polyglutamine (polyQ) repeats is the cytopathologic hallmark of a group of dominantly inherited neurodegenerative diseases, including Huntington’s disease (HD). Huntingtin (Htt), the disease protein of HD, forms amyloid-like fibrils by liquid-to-solid phase transition. Macroautophagy has been proposed to clear polyQ aggregates, but the efficiency of aggrephagy is limited. Here, we used cryo-electron tomography to visualize the interactions of autophagosomes with polyQ aggregates in cultured cells in situ. We found that an amorphous aggregate phase exists next to the radially organized polyQ fibrils. Autophagosomes preferentially engulfed this amorphous material, mediated by interactions between the autophagy receptor p62/SQSTM1 and the non-fibrillar aggregate surface. In contrast, amyloid fibrils excluded p62 and evaded clearance, resulting in trapping of autophagic structures. These results suggest that the limited efficiency of autophagy in clearing polyQ aggregates is due to the inability of autophagosomes to interact productively with the non-deformable, fibrillar disease aggregates.
PMID:38759629 | DOI:10.1016/j.molcel.2024.04.018
Add to Google Keep
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D
Cool Evidence: Engaging Young People and Students in Real-World Evidence ☀️
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
Autophagy preferentially degrades non-fibrillar polyQ aggregates
🌐 90 Days
VR Related Evidence Matrix
- Copper enhances aggregational toxicity of mutant huntingtin in a Drosophila model of Huntington's Disease
- HAP40 modulates mutant Huntingtin aggregation and toxicity in Huntington's disease mice
- Huntingtin CAG repeats in neuropathologically confirmed tauopathies: Novel insights
- Combined light and electron microscopy (CLEM) to quantify methamphetamine-induced alpha-synuclein-related pathology
- In situ studies of membrane biology by cryo-electron tomography
- In situ studies of membrane biology by cryo-electron tomography
- RNA as a component of scrapie fibrils
- Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissue
- Mutations in human prion-like domains: pathogenic but not always amyloidogenic
- Prevention of amyloid b fibril deposition on the synaptic membrane in the precuneus by ganglioside nanocluster-targeting inhibitors
- Regulated cell death and its role in Alzheimer's disease and amyotrophic lateral sclerosis
- Distinct ultrastructural phenotypes of glial and neuronal alpha-synuclein inclusions in multiple system atrophy
- Amyloid-beta antibody binding to cerebral amyloid angiopathy fibrils and risk for amyloid-related imaging abnormalities
- Engineering fibronectin-templated multi-component fibrillar extracellular matrices to modulate tissue-specific cell response
- Engineering fibronectin-templated multi-component fibrillar extracellular matrices to modulate tissue-specific cell response
- A CAG repeat threshold for therapeutics targeting somatic instability in Huntington's disease
- A CAG repeat threshold for therapeutics targeting somatic instability in Huntington's disease
- Autophagy and exosomes; inter-connected maestros in Alzheimer's disease
- Divergent Age-Dependent Conformational Rearrangement within Ab Amyloid Deposits in APP23, APPPS1, and AppNL-F Mice
- D-peptide-magnetic nanoparticles fragment tau fibrils and rescue behavioral deficits in a mouse model of Alzheimer's disease
- PPARs (Peroxisome Proliferator-activated Receptors) and Their Agonists in Alzheimer's Disease
- Proteomics Impact on Cell Biology to Resolve Cell Structure and Function
- How does the neurotoxin β-N-methylamino-L-alanine exist in biological matrices and cause toxicity?
- Selection of lansoprazole from an FDA-approved drug library to inhibit the Alzheimer's disease seed-dependent formation of tau aggregates
- Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets
- Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets
- Endovascular transplantation of mRNA-enhanced mesenchymal stromal cells results in superior therapeutic protein expression in swine heart
- Pathological C-terminal phosphomimetic substitutions alter the mechanism of liquid-liquid phase separation of TDP-43 low complexity domain
- Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial
- Precision proteoform design for 4R tau isoform selective templated aggregation
- In vivo PET classification of tau pathologies in patients with frontotemporal dementia
- Accumulation of neutral lipids in dystrophic neurites surrounding amyloid plaques in Alzheimer's disease
- Smell the smoke before one sees the fire-The oligosymptomatic prodromal phase of neurodegenerative diseases
- Detection of a-Synuclein in Oral Mucosa by Seed Amplification Assay in Synucleinopathies and Isolated REM Sleep Behavior Disorder
- Detection of a-Synuclein in Oral Mucosa by Seed Amplification Assay in Synucleinopathies and Isolated REM Sleep Behavior Disorder
- Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's disease
- The impact of IDR phosphorylation on the RNA binding profiles of proteins
- The impact of IDR phosphorylation on the RNA binding profiles of proteins
- Multiple system atrophy with amyloid-b-predominant Alzheimer's disease neuropathologic change
- Integration of Microfluidic Devices with Microelectrode Arrays to Functionally Assay Amyloid-β-Induced Synaptotoxicity
- NMDA receptor-mediated Ca2+ signaling: Impact on cell cycle regulation and the development of neurodegenerative diseases and cancer
- NMDA receptor-mediated Ca2+ signaling: Impact on cell cycle regulation and the development of neurodegenerative diseases and cancer
- How can we manage progressive supranuclear palsy syndrome with pharmacotherapy?
- Patient-derived neuron model: capturing age-dependent adult-onset degenerative pathology in Huntington's disease
- CAG repeat mosaicism is gene specific in spinocerebellar ataxias
- iPSC-derived models for anorexia nervosa research
- Genetic overlap between Alzheimer's disease and immune-mediated diseases: an atlas of shared genetic determinants and biological convergence
- Human cytomegalovirus degrades DMXL1 to inhibit autophagy, lysosomal acidification, and viral assembly
- Endo-lysosomal dysfunction in neurodegenerative diseases: opinion on current progress and future direction in the use of exosomes as biomarkers
- Pyrene Functionalized Norbornadiene-Quadricyclane Fluorescent Photoswitches: Characterization of their Spectral Properties and Application in Imaging of Amyloid Beta Plaques
- Orphan GPR52 as an emerging neurotherapeutic target
- Disease and brain region specific immune response profiles in neurodegenerative diseases with pure and mixed protein pathologies
- Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases
- Innate immune activation in neurodegenerative diseases
- Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside
- Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside
- The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillance
- The seeds of its regulation: natural antisense transcripts as single-gene control switches in neurodegenerative disorders
- Unraveling the Dual Role of ADAM10: Bridging the Gap between Cancer and Alzheimer's Disease
- Reduction of spermine synthase enhances autophagy to suppress Tau accumulation
- Single-nucleus RNA sequencing demonstrates an autosomal dominant Alzheimer's disease profile and possible mechanisms of disease protection
- A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Bioactive Peptides
- Perinatal loss of galactosylceramidase in both oligodendrocytes and microglia is crucial for the pathogenesis of Krabbe disease in mice
- Perinatal loss of galactosylceramidase in both oligodendrocytes and microglia is crucial for the pathogenesis of Krabbe disease in mice
Evidence Blueprint
Autophagy preferentially degrades non-fibrillar polyQ aggregates
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Autophagy preferentially degrades non-fibrillar polyQ aggregates
🌐 365 Days
VR Related Evidence Matrix
- Copper enhances aggregational toxicity of mutant huntingtin in a Drosophila model of Huntington's Disease
- Ribosomal protein SA is a common component of neuronal intranuclear inclusions in polyglutamine diseases and Marinesco bodies
- Secondary Protein Aggregates in Neurodegenerative Diseases: Almost the Rule Rather than the Exception
- HAP40 modulates mutant Huntingtin aggregation and toxicity in Huntington's disease mice
- Correction of symptoms of Huntington disease by genistein through FOXO3-mediated autophagy stimulation
- Huntingtin CAG repeats in neuropathologically confirmed tauopathies: Novel insights
- Toward the quantification of α-synuclein aggregates with digital seed amplification assays
- Cathepsin L prevents the accumulation of alpha-synuclein fibrils in the cell
- In Vivo Cerebral Imaging of Mutant Huntingtin Aggregates Using 11C-CHDI-180R PET in a Nonhuman Primate Model of Huntington Disease
- Super-resolution imaging unveils the self-replication of tau aggregates upon seeding
- The Urine Metabolome of R6/2 and zQ175DN Huntington's Disease Mouse Models
- Targeted degradation of SNCA/α-synuclein aggregates in neurodegeneration using the AUTOTAC chemical platform
- Comparison of Huntington's disease phenotype progression in male and female heterozygous FDNQ175 mice
- Arginine methylation of RNA-binding proteins is impaired in Huntington's disease
- Association of Copresence of Pathogenic Variants Related to Amyotrophic Lateral Sclerosis and Prognosis
- Aberrant splicing of mutant huntingtin in Huntington's disease knock-in pigs
- Presence of Extracellular Alpha-Synuclein Aggregates Trigger Astrocytic Degeneration Through Enhanced Membrane Rigidity and Deregulation of Store-Operated Calcium Entry (SOCE) into the Endoplasmic Reticulum
- Phosphorylation-state dependent intraneuronal sorting of Aβ differentially impairs autophagy and the endo-lysosomal system
- Disrupting pathologic phase transitions in neurodegeneration
- Combined light and electron microscopy (CLEM) to quantify methamphetamine-induced alpha-synuclein-related pathology
- Mutant huntingtin confers cell-autonomous phenotypes on Huntington's disease iPSC-derived microglia
- Human cystatin C induces the disaggregation process of selected amyloid beta peptides: a structural and kinetic view
- X-linked SBMA model mice display relevant non-neurological phenotypes and their expression of mutant androgen receptor protein in motor neurons is not required for neuromuscular disease
- Local structural preferences in shaping tau amyloid polymorphism
- Different Tau Fibril Types Reduce Prion Level In Chronically And De Novo Infected Cells
- Distribution of ubiquilin 2 and TDP-43 aggregates throughout the CNS in UBQLN2 p.T487I-linked amyotrophic lateral sclerosis and frontotemporal dementia
- In situ studies of membrane biology by cryo-electron tomography
- In situ studies of membrane biology by cryo-electron tomography
- RNA as a component of scrapie fibrils
- Lysosomal stress drives the release of pathogenic α-synuclein from macrophage lineage cells via the LRRK2-Rab10 pathway
- Cellular and animal models to investigate pathogenesis of amyloid aggregation in neurodegenerative diseases
- Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissue
- Mutations in human prion-like domains: pathogenic but not always amyloidogenic
- Lymphocyte-Activation Gene 3 Facilitates Pathological Tau Neuron-to-Neuron Transmission
- Mutant α-synuclein propagates via the lymphatic system of the brain in the monomeric state
- Amyloid fibril proteomics of AD brains reveals modifiers of aggregation and toxicity
- Prevention of amyloid b fibril deposition on the synaptic membrane in the precuneus by ganglioside nanocluster-targeting inhibitors
- Alzheimer's disease biomarker analysis using targeted mass spectrometry
- Pathological α-synuclein detected by real-time quaking-induced conversion in synucleinopathies
- CSF protein ratios with enhanced potential to reflect Alzheimer's disease pathology and neurodegeneration
- Damage to the orbicularis oculi muscle may impair the development of dermatochalasis
- Direct Reprogramming of Somatic Skin Cells from a Patient with Huntington's Disease into Striatal Neurons to Create Models of Pathology
- Molecular pathology of neurodegenerative diseases by cryo-EM of amyloids
- Synapses do not facilitate prion-like transfer of alpha-synuclein: a quantitative study in reconstructed unidirectional neural networks
- Hydrodynamic Control of Alzheimer Aβ Fibrillation with Glucosaminic Acid Containing Click-Cyclized β-Bodies
- Regulated cell death and its role in Alzheimer's disease and amyotrophic lateral sclerosis
- Distinct ultrastructural phenotypes of glial and neuronal alpha-synuclein inclusions in multiple system atrophy
- Cryo-EM structures of tau filaments from SH-SY5Y cells seeded with brain extracts from cases of Alzheimer's disease and corticobasal degeneration
- Sortilin acts as an endocytic receptor for α-synuclein fibril
- The GRP78-PERK axis contributes to memory and synaptic impairments in Huntington's disease R6/1 mice
- The GRP78-PERK axis contributes to memory and synaptic impairments in Huntington's disease R6/1 mice
- Therapeutic advances in neural regeneration for Huntington's disease
- Amyloid-beta antibody binding to cerebral amyloid angiopathy fibrils and risk for amyloid-related imaging abnormalities
- Head-to-head comparison of [18F]-Flortaucipir, [18F]-MK-6240 and [18F]-PI-2620 postmortem binding across the spectrum of neurodegenerative diseases
- Soluble mutant huntingtin drives early human pathogenesis in Huntington's disease
- Purinergic receptors in cognitive disturbances
- Engineering fibronectin-templated multi-component fibrillar extracellular matrices to modulate tissue-specific cell response
- Engineering fibronectin-templated multi-component fibrillar extracellular matrices to modulate tissue-specific cell response
- A CAG repeat threshold for therapeutics targeting somatic instability in Huntington's disease
- A CAG repeat threshold for therapeutics targeting somatic instability in Huntington's disease
- Targeted examination of amyloid beta and tau protein accumulation via positron emission tomography for the differential diagnosis of Alzheimer's disease based on the A/T(N) research framework
- Autophagy and exosomes; inter-connected maestros in Alzheimer's disease
- Brain organoids: A revolutionary tool for modeling neurological disorders and development of therapeutics
- Divergent Age-Dependent Conformational Rearrangement within Ab Amyloid Deposits in APP23, APPPS1, and AppNL-F Mice